Mackenzie Financial’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.61M | Sell |
17,260
-2,046
| -11% | -$554K | 0.01% | 689 |
|
|
2025
Q4 | $4.88M | Buy |
19,306
+4,987
| +35% | +$1.32M | 0.01% | 646 |
|
|
2025
Q3 | $4.11M | Sell |
14,319
-13,039
| -48% | -$3.49M | 0.01% | 674 |
|
|
2025
Q2 | $7.18M | Sell |
27,358
-5,488
| -17% | -$1.34M | 0.01% | 536 |
|
|
2025
Q1 | $7.64M | Buy |
32,846
+21,456
| +188% | +$5.21M | 0.01% | 501 |
|
|
2024
Q4 | $2.61M | Sell |
11,390
-1,405
| -11% | -$322K | ﹤0.01% | 701 |
|
|
2024
Q3 | $2.86M | Sell |
12,795
-589
| -4% | -$129K | ﹤0.01% | 651 |
|
|
2024
Q2 | $2.72M | Buy |
13,384
+5,275
| +65% | +$1.07M | ﹤0.01% | 664 |
|
|
2024
Q1 | $1.77M | Sell |
8,109
-9,501
| -54% | -$2.09M | ﹤0.01% | 765 |
|
|
2023
Q4 | $4M | Buy |
17,610
+1,507
| +9% | +$317K | 0.01% | 600 |
|
|
2023
Q3 | $3.23M | Sell |
16,103
-1,929
| -11% | -$407K | 0.01% | 620 |
|
|
2023
Q2 | $3.24M | Sell |
18,032
-2,316
| -11% | -$449K | ﹤0.01% | 642 |
|
|
2023
Q1 | $4.01M | Sell |
20,348
-165
| -0.8% | -$34K | 0.01% | 592 |
|
|
2022
Q4 | $4.15M | Buy |
20,513
+1,919
| +10% | +$375K | 0.01% | 547 |
|
|
2022
Q3 | $3.27M | Sell |
18,594
-858
| -4% | -$176K | 0.01% | 594 |
|
|
2022
Q2 | $3.92M | Buy |
19,452
+9,794
| +101% | +$2.09M | 0.01% | 580 |
|
|
2022
Q1 | $2.19M | Buy |
9,658
+635
| +7% | +$149K | ﹤0.01% | 738 |
|
|
2021
Q4 | $2.44M | Sell |
9,023
-5,074
| -36% | -$1.26M | ﹤0.01% | 736 |
|
|
2021
Q3 | $3.41M | Buy |
14,097
+2,724
| +24% | +$686K | ﹤0.01% | 642 |
|
|
2021
Q2 | $2.69M | Buy |
11,373
+700
| +7% | +$159K | ﹤0.01% | 670 |
|
|
2021
Q1 | $2.34M | Sell |
10,673
-10,824
| -50% | -$2.17M | ﹤0.01% | 660 |
|
|
2020
Q4 | $3.76M | Buy |
21,497
+8,144
| +61% | +$1.41M | 0.01% | 491 |
|
|
2020
Q3 | $2.16M | Buy |
13,353
+73
| +0.5% | +$11.6K | 0.01% | 544 |
|
|
2020
Q2 | $1.9M | Sell |
13,280
-18,947
| -59% | -$2.62M | 0.01% | 573 |
|
|
2020
Q1 | $3.5M | Buy |
32,227
+103
| +0.3% | +$14.8K | 0.01% | 393 |
|
|
2019
Q4 | $4.67M | Buy |
32,124
+1,116
| +4% | +$161K | 0.01% | 455 |
|
|
2019
Q3 | $4.47M | Sell |
31,008
-23
| -0.1% | -$3.36K | 0.01% | 468 |
|
|
2019
Q2 | $4.61M | Sell |
31,031
-91
| -0.3% | -$12.7K | 0.01% | 462 |
|
|
2019
Q1 | $4.09M | Buy |
31,122
+18,674
| +150% | +$2.3M | 0.01% | 587 |
|
|
2018
Q4 | $1.35M | Buy |
+12,448
| New | +$1.67M | ﹤0.01% | 768 |
|
Other funds holding LH
VCM
VPM
Mackenzie Financial's LH Position: Q1 2026 in Review
Mackenzie Financial reduced its Labcorp (LH) stake by 11% in Q1 2026, selling an estimated $554K and leaving 17,260 shares worth $4.61M. The position accounts for 0.01% of the portfolio, ranked #689.
Mackenzie Financial first reported a position in LH in Q4 2018 and has held it in 30 quarters since. The position peaked at $7.64M in Q1 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Mackenzie Financial held 17,260 shares of Labcorp worth $4.61M as of Q1 2026.
- Mackenzie Financial sold 2,046 Labcorp shares in Q1 2026, an estimated $554K.
- Labcorp made up 0.01% of Mackenzie Financial's portfolio in Q1 2026, its #689 holding.
- Mackenzie Financial first reported a position in Labcorp in Q4 2018 and has held it in 30 quarters since.
- Mackenzie Financial's Labcorp position peaked at $7.64M in Q1 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.